- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02964117
Associations Between Air Pollutants Exposures and Respiratory System Study
November 10, 2016 updated by: Bei He, Peking University Third Hospital
Epidemiological investigations has suggested exposure to air pollution linked with respiratory disease, especially chronic obstructive pulmonary disease.
However, the potential mechanisms of adverse effects remains scare.
The present study will assess the association between air pollutants and respiratory related parameters to elucidate possible mechanisms.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
106
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
23 years to 82 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects including health volunteers and COPD patients,both of them without severe cardiopulmonary diseases and long-term residents in Beijing
Description
Inclusion Criteria:
- Long-term residents, aged >23 and <82 years
Exclusion Criteria:
- Severe cardiopulmonary diseases, active inflammatory diseases, cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung Function indices were performed in peking university third hospital
Time Frame: Repeated-measure study was conducted from November,2014 to January,2016,lung function was measured by every four months
|
Lung Function indices including FEV1(ml), FVC(ml),the ratio of FEV1/FVC et, al..
When we perform data analysis,these parameters will be expressed as the percentage of the predicted values based on the subject-specific sex, age,height and weight.
|
Repeated-measure study was conducted from November,2014 to January,2016,lung function was measured by every four months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inflammation related biomarkers were measured by flow cytometry
Time Frame: Repeated-measure study was conducted from November,2014 to January,2016,biomarkers were measured by every four months
|
Inflammation related factors including IL,TNFa et, al. all biomarkers units are pg/ml.
|
Repeated-measure study was conducted from November,2014 to January,2016,biomarkers were measured by every four months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Bei He, MD/Ph.D, Peking University Third Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
October 31, 2016
First Submitted That Met QC Criteria
November 10, 2016
First Posted (Estimate)
November 15, 2016
Study Record Updates
Last Update Posted (Estimate)
November 15, 2016
Last Update Submitted That Met QC Criteria
November 10, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Apers Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.